Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Ajalaya Teyateeti,1,2 Armeen Mahvash,3 James P Long,4 Mohamed E Abdelsalam,3 Rony Avritscher,3 Beth Chasen,1 Ahmed O Kaseb,5 Joshua D Kuban,3 Ravi Murthy,3 Bruno C Odisio,3 Achiraya Teyateeti,6 Homer A Macapinlac,1 S Cheenu Kappadath7 1Department of Nuclear Medicine, Division of Diagnostic Imaging,...

Full description

Bibliographic Details
Main Authors: Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Macapinlac HA, Kappadath SC
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
y90
selective internal radiation therapy
therasphere
prognostic factors
adverse events
Online Access:https://www.dovepress.com/survival-outcomes-for-yttrium-90-transarterial-radioembolization-with--peer-reviewed-article-JHC

Internet

https://www.dovepress.com/survival-outcomes-for-yttrium-90-transarterial-radioembolization-with--peer-reviewed-article-JHC

Similar Items